In October 2013, Warner Chilcott plc, Warner Chilcott Sales’ indirect parent corporation, became a wholly-owned subsidiary of Actavis plc. In March 2015, Actavis plc completed an acquisition of
Chaudhuri will report to Rajiv Malik, president of Mylan. Chaudhuri joins Mylan from GlaxoSmithKline (GSK) Consumer Healthcare, where he served for nearly three decades, and brings to Mylan
These findings are a step forward in the development of targeted therapies for hard-to-treat cancers. The American Cancer Society estimates that in 2015, about 21,290 new cases of
FDA’s Fast Track program facilitates the development and review of drugs intended to treat serious conditions and address an unmet medical need. A drug development program with Fast
TTIL will support a Phase 2 study to evaluate selective androgen receptor modulator (SARM) drug candidate TT701 as a therapy to improve the symptoms of androgen deficiency in
Under the agreement, WuXi will equip and operate a dedicated, fully cGMP-compliant 12,500-square-foot analytical testing facility in Shanghai. The facility will provide analytical and stability services, including analytical
The company’s latest report states that this increase, which will occur across the eight major markets of the US, France, Germany, Italy, Spain, UK, Japan, and urban China,
Pfizer’s current PCMM prototype is an autonomous and transportable pod that may be quickly shipped from location to location and readily brought online to create a fully functional
This trial is the first to evaluate the safety and efficacy of OCA in Japanese NASH patients. The primary efficacy analysis was conducted on an intention to treat
The companies will use CEVEC’s CAPGo technology which is optimal for the production of these otherwise difficult to produce recombinant glycoproteins. Financial details of this agreement were not
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.